5 results match your criteria: "Fundação Antonio Prudente- A C Camargo Cancer Center[Affiliation]"
Rev Bras Enferm
December 2024
Fundação Antônio Prudente A.C.Camargo Cancer Center. São Paulo, São Paulo, Brazil.
Intensive Care Med
September 2024
Fundação Antonio Prudente- A C Camargo Cancer Center, São Paulo, SP, Brazil.
Ann Surg Oncol
June 2024
Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
Background: The impact of coronavirus disease 2019 (COVID-19) on postoperative recovery from oncology surgeries should be understood for the clinical decision-making. Therefore, this study was designed to evaluate the postoperative cumulative 28-day mortality and the morbidity of surgical oncology patients during the COVID-19 pandemic.
Methods: This retrospective cohort study included patients consecutively admitted to intensive care units (ICU) of three centres for postoperative care of oncologic surgeries between March to June 2019 (first phase) and March to June 2020 (second phase).
Appl Neuropsychol Child
June 2022
Departamento de Psicobiologia, Escola Paulista de Medicina, Universidade Federal de São Paulo, São Paulo, Brazil.
Pediatric cancer treatment can negatively impact cognitive and psychosocial development, although it has been suggested that these adverse effects may be minimized when children have higher resilience and better executive functioning. We aimed to evaluate the impact of pediatric Acute Lymphoblastic Leukemia (ALL) treatment on executive function, resilience and stress in survivors and to investigate correlations between executive functioning and resilience and between executive functioning and stress. The neuropsychological assessment was performed in 32 ALL survivors aged 7-17 years and 28 age-, sex- and socioeconomic status matched controls.
View Article and Find Full Text PDFInt Braz J Urol
February 2015
2 Division of Urology, Fundação Antonio Prudente A. C. Camargo Cancer Center, São Paulo - SP, Brazil.
Introduction: Positive surgical margins (PSMs) are an adverse factor that may predict a worse outcome in patients submitted to radical prostatectomy (RP). However, not all of these cases will evolve to biochemical (BCR) or clinical (CR) recurrence, therefore relationship between PSMs and these recurrent events has to be correlated with other clinical and pathologic findings to indicate complementary treatment for selected patients.
Materials And Methods: Of 1250 patients submitted to open retropubic radical prostatectomy (RRP), between March 1991 and June 2008, the outcome of 161 patients with PSMs and of 67 without PSMs as a control group, comprising a total of 228 cases were retrospectively reviewed.